Cargando…
Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay
Cytotoxicity of the futuristic nanogenomedicine (e.g., short interfering RNA and antisense) may hamper its clinical development. Of these, the gene-based medicine and/or its carrier may elicit cellular toxicity. For assessment of such cytotoxicity, a common methodology is largely dependent upon util...
Autores principales: | Ahmadian, Somaieh, Barar, Jaleh, Saei, Amir Ata, Fakhree, Mohammad Amin Abolghassemi, Omidi, Yadollah |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791085/ https://www.ncbi.nlm.nih.gov/pubmed/19352311 http://dx.doi.org/10.3791/1191 |
Ejemplares similares
-
Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
por: Omidi, Yadollah, et al.
Publicado: (2014) -
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer
por: Barar, Jaleh, et al.
Publicado: (2014) -
Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies
por: Barar, Jaleh, et al.
Publicado: (2015) -
Novel water-soluble polyurethane nanomicelles for cancer chemotherapy: physicochemical characterization and cellular activities
por: Khosroushahi, Ahmad Yari, et al.
Publicado: (2012) -
Hydrogels for ocular drug delivery and tissue engineering
por: Fathi, Marzieh, et al.
Publicado: (2015)